Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BMEABiomea Fusion, Inc.

Nasdaq · CIK 0001840439
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts224

Identity from submissions API

NameBiomea Fusion, Inc.
CIK0001840439
TickersBMEA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 980-9099
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1599 INDUSTRIAL ROAD
SAN CARLOS
CA
94070
CA
Mailing address
1599 INDUSTRIAL ROAD
SAN CARLOS
CA
94070
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

292 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 10-Q 10-Q 0001193125-26-455592 001-40335 261540940 34 8970078 1 1
2026-11-10 8-K 8-K 9.01 0001193125-26-455557 001-40335 261540812 34 351774 1 1
2026-10-14 8-K 8-K 7.01,8.01,9.01 0001193125-26-420684 001-40335 261457794 34 8510287 1 1
2026-09-22 424B5 424B5 0001193125-26-397909 333-289262 261396931 33 1365318
2026-09-22 8-K 8-K 8.01 0001193125-26-397870 001-40335 261396850 34 147656 1 1
2026-08-05 10-Q 10-Q 0001193125-26-335085 001-40335 261243536 34 8422382 1 1
2026-08-05 8-K 8-K 9.01 0001193125-26-335073 001-40335 261243475 34 335161 1 1
2026-06-12 4 4 0001193125-26-269470 5502
2026-06-12 4 4 0001193125-26-269469 5477
2026-06-12 4 4 0001193125-26-269468 5479
2026-06-12 4 4 0001193125-26-269465 5476
2026-06-11 8-K 8-K 5.07 0001193125-26-266687 001-40335 261081431 34 144234 1 1
2026-05-11 10-Q 10-Q 0001193125-26-217074 001-40335 26964283 34 7607778 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001193125-26-217037 001-40335 26964213 34 282770 1 1
2026-04-28 8-K 8-K 7.01,8.01,9.01 0001193125-26-183710 001-40335 26903288 34 3518912 1 1
2026-04-27 DEF 14A DEF 14A 0001193125-26-182080 001-40335 26900947 34 2841632 1 1
2026-04-27 ARS ARS 0001193125-26-182038 001-40335 26900827 34 1462758
2026-04-03 4 4 0001193125-26-142178 5590
2026-04-03 4 4 0001193125-26-142177 5580
2026-03-24 10-K 10-K 0001193125-26-121825 001-40335 26786323 34 17028835 1 1
2026-03-24 8-K 8-K 2.02,9.01 0001193125-26-121811 001-40335 26786263 34 283999 1 1
2026-02-25 8-K 8-K 7.01,9.01 0001193125-26-068375 001-40335 26674033 34 16133208 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-26-000021 005-92506 26639886 34 11588
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-26-004993 005-92506 26626057 34 7513
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-041263 005-92506 26608104 34 8353
2026-02-06 5 5 0001193125-26-041207 14404
2026-01-14 8-K 8-K 7.01,8.01,9.01 0001193125-26-012908 001-40335 26533308 34 24736389 1 1
2026-01-06 S-8 S-8 0001193125-26-004374 333-292588 26511317 33 196900 1 1
2025-12-15 4 4 0001193125-25-319222 11987
2025-12-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000333 005-92506 251555155 34 9310
2025-12-04 4 4 0001193125-25-308091 4896
2025-12-02 4 4 0001193125-25-305287 13357
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-042300 005-92506 251485822 34 6968
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000192 005-92506 251463340 34 11642
2025-11-04 10-Q 10-Q 0001193125-25-264679 001-40335 251449057 34 8704229 1 1
2025-11-04 8-K 8-K 2.02,9.01 0001193125-25-264631 001-40335 251448855 34 327070 1 1
2025-10-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000929638-25-003999 005-92506 251416290 34 13152
2025-10-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000929638-25-003884 005-92506 251388164 34 12199
2025-10-07 8-K 8-K 1.01,8.01,9.01 0001193125-25-233614 001-40335 251380527 34 815435 1 1
2025-10-07 424B5 424B5 0001193125-25-233589 333-289262 251380456 33 639981
2025-10-06 424B5 424B5 0001193125-25-232037 333-289262 251377484 33 637947
2025-10-06 8-K 8-K 8.01 0001193125-25-231903 001-40335 251377027 34 151222 1 1
2025-08-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002637 333-289262 251226179 33 1708
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-108074 005-92506 251212144 34 11314
2025-08-13 4 4 0000950170-25-108045 5348
2025-08-13 4 4 0000950170-25-108041 20347
2025-08-13 CORRESP filename1.htm 0001193125-25-179812 6633
2025-08-12 UPLOAD filename1.pdf 0000000000-25-008473 333-289262 40130
2025-08-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-030266 005-92506 251203291 34 6860
2025-08-05 S-3 S-3 0000950170-25-103144 333-289262 251185648 33 2782133 1 1
2025-08-05 10-Q 10-Q 0000950170-25-103041 001-40335 251185071 34 7847273 1 1
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-103023 001-40335 251184939 34 358934 1 1
2025-08-01 4 xslF345X05/form4.xml 0000929638-25-002849 17157
2025-07-24 4 4 0000950170-25-098343 5265
2025-07-24 3 3 0000950170-25-098337 18879
2025-07-24 8-K 8-K 5.02,9.01 0001193125-25-163815 001-40335 251144509 34 154942 1 1
2025-07-22 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000929638-25-002664 005-92506 251141035 34 12202
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002486 005-92506 251128434 34 10747
2025-06-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000113 005-92506 251071496 34 15902
2025-06-20 8-K 8-K 1.01,9.01 0001193125-25-143747 001-40335 251062279 34 616184 1 1
2025-06-18 8-K 8-K 1.01,8.01,9.01 0001193125-25-142830 001-40335 251057963 34 674860 1 1
2025-06-18 424B5 424B5 0001193125-25-142828 333-267884 251057951 33 728393
2025-06-17 424B5 424B5 0001193125-25-142132 333-267884 251054153 33 731432
2025-06-17 8-K 8-K 7.01,8.01,9.01 0001193125-25-142126 001-40335 251054047 34 24953237 1 1
2025-06-13 4 4 0000950170-25-086193 5422
2025-06-13 4 4 0000950170-25-086191 5382
2025-06-13 4 4 0000950170-25-086190 5401
2025-06-13 4 xslF345X05/form4.xml 0000929638-25-002234 17501
2025-06-13 8-K 8-K 5.07 0001193125-25-140718 001-40335 251046324 34 155095 1 1
2025-05-05 10-Q 10-Q 0000950170-25-063543 001-40335 25913026 34 6685941 1 1
2025-05-05 8-K 8-K 2.02,9.01 0000950170-25-063523 001-40335 25912856 34 331275 1 1
2025-04-28 ARS ARS 0001193125-25-100494 001-40335 25880419 34 4741167
2025-04-28 DEF 14A DEF 14A 0001193125-25-100455 001-40335 25880258 34 1652746 1 1
2025-04-18 PRE 14A PRE 14A 0001193125-25-085769 001-40335 25850550 34 1662457 1 1
2025-03-31 10-K 10-K 0000950170-25-047775 001-40335 25793622 34 21919227 1 1
2025-03-31 8-K 8-K 2.02,9.01 0000950170-25-047755 001-40335 25793502 34 359566 1 1
2025-03-28 4 4 0000950170-25-046790 5366
2025-03-27 8-K 8-K 3.01,5.02,7.01,9.01 0001193125-25-065564 001-40335 25779981 34 176537 1 1
2025-02-28 8-K 8-K 5.02 0001193125-25-042468 001-40335 25690005 34 148026 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014084 005-92506 25628766 34 13813
2025-01-15 8-K 8-K 8.01,9.01 0001193125-25-007107 001-40335 25533517 34 10112730 1 1
2025-01-06 S-8 S-8 0001193125-25-002209 333-284148 25512051 33 96423
2024-12-20 8-K 8-K 7.01,8.01,9.01 0001193125-24-283008 001-40335 241567528 34 11146649 1 1
2024-12-02 4 4 0000950170-24-132253 4894
2024-11-12 SC 13G/A LAURION CAPITAL MANAGEMENT LP 0001085146-24-005527 005-92506 241446088 34 45429
2024-10-31 8-K 8-K 7.01,8.01,9.01 0001193125-24-248083 001-40335 241412216 34 3370721 1 1
2024-10-29 10-Q 10-Q 0000950170-24-118366 001-40335 241406724 34 5407597 1 1
2024-10-29 8-K 8-K 2.02,9.01 0000950170-24-118344 001-40335 241406580 34 316549 1 1
2024-10-01 4 4 0000950170-24-110858 4391
2024-09-27 8-K 8-K 8.01,9.01 0001193125-24-227940 001-40335 241334808 34 176224 1 1
2024-07-31 10-Q 10-Q 0000950170-24-088584 001-40335 241162118 34 5271421 1 1
2024-07-31 8-K 8-K 2.02,9.01 0000950170-24-088581 001-40335 241162079 34 308894 1 1
2024-07-18 UPLOAD filename1.pdf 0000000000-24-008181 001-40335 39666
2024-07-10 SC 13G/A Biomea_Fusion_Inc.txt 0000093751-24-000656 005-92506 241108651 34 8454
2024-06-21 CORRESP filename1.htm 0001193125-24-165635 27243
2024-06-13 4 xslF345X05/form4.xml 0000929638-24-002175 16252
2024-06-13 4 4 0000950170-24-073075 5409
2024-06-13 4 4 0000950170-24-073074 5430
2024-06-13 4 4 0000950170-24-073069 5441
2024-06-13 4 4 0000950170-24-073068 5390
2024-06-12 8-K 8-K 5.07 0001193125-24-160033 001-40335 241039200 34 154567 1 1
2024-06-12 4 4 0000950170-24-072494 6768
2024-06-12 4 4 0000950170-24-072493 4979
2024-06-12 UPLOAD filename1.pdf 0000000000-24-006750 001-40335 43935
2024-06-07 8-K 8-K 8.01,9.01 0001193125-24-157310 001-40335 241029181 34 173920 1 1
2024-05-02 8-K 8-K 2.02,9.01 0000950170-24-052121 001-40335 24908382 34 274730 1 1
2024-05-02 10-Q 10-Q 0000950170-24-052082 001-40335 24908130 34 5363300 1 1
2024-04-26 ARS ARS 0001193125-24-117992 001-40335 24883664 34 109627080
2024-04-26 DEF 14A DEF 14A 0001193125-24-117942 001-40335 24883410 34 821186
2024-04-10 SC 13G Biomea_Fusion_Inc.txt 0000093751-24-000576 005-92506 24834404 34 10342
2024-04-01 8-K 8-K 8.01,9.01 0001193125-24-083352 001-40335 24809152 34 193087 1 1
2024-04-01 8-K 8-K 2.02,9.01 0000950170-24-039304 001-40335 24809086 34 326402 1 1
2024-03-28 10-K 10-K 0000950170-24-038026 001-40335 24798807 34 15798642 1 1
2024-03-07 8-K 8-K 8.01,9.01 0001193125-24-062154 001-40335 24729960 34 2911335 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023725 005-92506 24638751 34 68825
2024-02-12 SC 13G/A SC 13G/A 0001193125-24-032239 005-92506 24621013 34 75196
2024-02-12 SC 13G/A SC 13G/A 0001193125-24-032238 005-92506 24621014 34 71147
2024-02-12 SC 13G/A JHG OWNS <5% 0001274173-24-000006 005-92506 24618754 34 10127
2024-02-09 SC 13G/A filing.txt 0000315066-24-000985 005-92506 24611339 34 8231
2024-02-08 SC 13G laurion-bmea123123.htm 0001172661-24-000546 005-92506 24607889 34 101244
2024-01-29 SC 13G us09077a1060_012924.txt 0001086364-24-005526 005-92506 24574876 34 13489
2024-01-18 4 4 0000950170-24-005417 5307
2024-01-18 4 4 0000950170-24-005415 5297
2024-01-18 4 4 0000950170-24-005416 5257
2024-01-18 4 4 0000950170-24-005414 5348
2024-01-10 8-K 8-K 8.01,9.01 0001193125-24-005929 001-40335 24526628 34 14917248 1 1
2024-01-05 S-8 S-8 0001193125-24-003349 333-276391 24516185 33 326363
2024-01-03 4 4 0000950170-24-000956 18806
2023-12-01 4 4 0000950170-23-067424 4809
2023-10-30 10-Q 10-Q 0000950170-23-056381 001-40335 231360742 34 7682767 1 1
2023-10-30 8-K 8-K 2.02,9.01 0000950170-23-056335 001-40335 231360210 34 371662 1 1
2023-09-01 4 4 0000950170-23-046099 5491
2023-09-01 3 3 0000950170-23-046092 7490
2023-07-31 10-Q 10-Q 0000950170-23-035946 001-40335 231127546 34 8195708 1 1
2023-07-31 8-K 8-K 2.02,9.01 0000950170-23-035939 001-40335 231127470 34 421752 1 1
2023-07-25 8-K 8-K 8.01,9.01 0001193125-23-193428 001-40335 231108583 34 180091 1 1
2023-06-16 4 4 0000950170-23-028679 5354
2023-06-16 4 xslF345X04/form4.xml 0000929638-23-001746 14811
2023-06-16 4 4 0000950170-23-028671 5404
2023-06-16 4 4 0000950170-23-028670 5322
2023-06-16 4 4 0000950170-23-028668 5306
2023-06-15 8-K 8-K 5.07 0001193125-23-167884 001-40335 231017359 34 154002 1 1
2023-06-02 4 4 0000950170-23-026142 4808
2023-06-02 4 PRIMARY DOCUMENT 0001859061-23-000007 6766
2023-05-19 144 xsl144X01/primary_doc.xml 0001974158-23-000008 001-40335 23941114 33 6700
2023-05-17 4 PRIMARY DOCUMENT 0001859061-23-000006 4919
2023-05-10 4 PRIMARY DOCUMENT 0001859061-23-000005 6775
2023-05-10 SC 13G filing.txt 0000315066-23-002270 005-92506 23904695 34 8124
2023-05-02 8-K 8-K 8.01,9.01 0001193125-23-132621 001-40335 23880207 34 179332 1 1
2023-05-02 10-Q 10-Q 0000950170-23-016700 001-40335 23879372 34 7429160 1 1
2023-05-02 8-K 8-K 2.02,9.01 0000950170-23-016684 001-40335 23879078 34 352794 1 1
2023-04-28 ARS ARS 0001193125-23-126935 001-40335 23866147 34 8126910
2023-04-28 DEF 14A DEF 14A 0001193125-23-126879 001-40335 23865905 34 793181
2023-04-27 144 xsl144X01/primary_doc.xml 0001969223-23-000050 001-40335 23852850 33 5566
2023-04-26 4 PRIMARY DOCUMENT 0001859061-23-000004 4925
2023-04-20 144 xsl144X01/primary_doc.xml 0001974158-23-000001 001-40335 23834112 33 4885
2023-04-06 4/A PRIMARY DOCUMENT 0001859061-23-000003 4908
2023-04-06 4 PRIMARY DOCUMENT 0001859061-23-000002 4751
2023-04-03 SC 13D/A AMENDMENT NO. 1 0000929638-23-001060 005-92506 23793334 34 86234
2023-04-03 4 xslF345X04/form4.xml 0000929638-23-001057 13472
2023-04-03 8-K 8-K 1.01,8.01,9.01 0001193125-23-089530 001-40335 23792634 34 464344 1 1
2023-03-30 424B5 424B5 0001193125-23-085519 333-267884 23780673 33 611179
2023-03-29 424B5 424B5 0001193125-23-082849 333-267884 23771709 33 614434
2023-03-28 8-K 8-K 7.01,8.01,9.01 0001193125-23-082314 001-40335 23770496 34 8029968 1 1
2023-03-28 10-K 10-K 0000950170-23-010312 001-40335 23769981 34 17508006 1 1
2023-03-28 8-K 8-K 2.02,9.01 0000950170-23-010286 001-40335 23769656 34 417777 1 1
2023-02-14 SC 13G SC 13G 0001104659-23-021471 005-92506 23628437 34 102313
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032871 005-92506 23613461 34 72993
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032687 005-92506 23612544 34 70564
2023-02-10 5 FORM 5 SUBMISSION 0000899243-23-004578 26101
2023-02-10 4/A FORM 4/A SUBMISSION 0000899243-23-004569 8023
2023-02-10 SC 13G/A JHG PLC OWNS >5% 0001274173-23-000039 005-92506 23609533 34 10420
2023-01-12 8-K 8-K 8.01,9.01 0001193125-23-007186 001-40335 23526002 34 24212801 1 1
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001487 5411
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001486 5370
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001484 5422
2023-01-04 S-8 S-8 0001193125-23-001489 333-269112 23506328 33 102060
2022-12-16 8-K 8-K 8.01,9.01 0001193125-22-307318 001-40335 221468017 34 181274 1 1
2022-12-13 8-K 8-K 8.01,9.01 0001193125-22-303796 001-40335 221459873 34 729419 1 1
2022-12-02 4 FORM 4 SUBMISSION 0000899243-22-037438 5006
2022-11-25 8-K 8-K 1.01,9.01 0001193125-22-292554 001-40335 221419697 34 433684 1 1
2022-11-25 424B5 424B5 0001193125-22-292548 333-267884 221419660 33 494635
2022-11-16 4 FORM 4 SUBMISSION 0000899243-22-036010 5098
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035697 5075
2022-11-07 10-Q 10-Q 0000950170-22-022607 001-40335 221365590 34 9223808 1 1
2022-11-07 8-K 8-K 2.02,9.01 0000950170-22-022598 001-40335 221365464 34 412711 1 1
2022-11-01 8-K 8-K 8.01,9.01 0001193125-22-274908 001-40335 221350229 34 177151 1 1
2022-10-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-10-24 16:01:00 9999999995-22-003124 333-267884 221327070 33 1716
2022-10-20 CORRESP filename1.htm 0001193125-22-265930 5816
2022-10-19 UPLOAD filename1.pdf 0000000000-22-011507 40181
2022-10-18 8-K 8-K 8.01,9.01 0001193125-22-264447 001-40335 221316066 34 180581 1 1
2022-10-14 S-3 S-3 0001193125-22-262931 333-267884 221311459 33 1012423
2022-09-23 8-K 8-K 8.01,9.01 0001193125-22-249373 001-40335 221260315 34 10238757 1 1
2022-09-22 8-K 8-K 8.01,9.01 0001193125-22-248476 001-40335 221257456 34 4910847 1 1
2022-09-09 8-K 8-K 1.01,2.03,9.01 0001193125-22-241932 001-40335 221236045 34 357681 1 1
2022-08-29 8-K 8-K 8.01,9.01 0001193125-22-231908 001-40335 221207210 34 2231038 1 1
2022-08-19 4 PRIMARY DOCUMENT 0001859061-22-000002 4892
2022-08-01 10-Q 10-Q 0000950170-22-013678 001-40335 221125049 34 8660973 1 1
2022-08-01 8-K 8-K 2.02,9.01 0000950170-22-013673 001-40335 221124872 34 390047 1 1
2022-07-25 4 PRIMARY DOCUMENT 0001859061-22-000001 4839
2022-07-08 SC 13G us09077a1060_070822.txt 0000834237-22-010208 005-92506 221074942 34 12268
2022-06-28 4 PRIMARY DOCUMENT 0001856641-22-000001 4497
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024058 5524
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024056 10367
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024053 10295
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024051 5493
2022-06-24 3 FORM 3 SUBMISSION 0000899243-22-024028 7755
2022-06-24 4 FORM 4 0001567619-22-013359 14234
2022-06-23 8-K 8-K 5.07 0001193125-22-180040 001-40335 221035414 34 155668 1 1
2022-06-06 8-K 8-K 8.01,9.01 0001193125-22-168339 001-40335 22998247 34 1093551 1 1
2022-06-03 4 FORM 4 SUBMISSION 0000899243-22-021082 5476
2022-06-01 4 FORM 4 SUBMISSION 0000899243-22-020517 5001
2022-05-16 10-Q 10-Q 0000950170-22-009947 001-40335 22925531 34 7931448 1 1
2022-05-16 8-K 8-K 2.02,9.01 0000950170-22-009945 001-40335 22925517 34 318625 1 1
2022-04-29 DEFA14A DEFA14A 0001193125-22-133667 001-40335 22875465 34 1847127
2022-04-29 DEF 14A DEF 14A 0001193125-22-133569 001-40335 22875227 34 878000
2022-04-22 8-K 8-K 5.02,9.01 0001193125-22-114094 001-40335 22843240 34 166346 1 1
2022-04-08 8-K 8-K 8.01,9.01 0001193125-22-100349 001-40335 22817212 34 1744128 1 1
2022-03-07 4 FORM 4 SUBMISSION 0000899243-22-009752 10255
2022-02-28 10-K 10-K 0001564590-22-007624 001-40335 22689779 34 13855530 1 1
2022-02-28 8-K 8-K 2.02,9.01 0001564590-22-007616 001-40335 22689397 34 552011 1 1
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041691 005-92506 22631856 34 90245
2022-02-11 SC 13G SC 13G 0001193125-22-037077 005-92506 22621190 34 97163
2022-02-11 SC 13G SC 13G 0001193125-22-037064 005-92506 22621145 34 100498
2022-02-10 SC 13G/A JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-22-000020 005-92506 22613547 34 10522
2022-02-04 SC 13G us09077a1060_020422.txt 0000834237-22-007155 005-92506 22593430 34 13141
2022-02-02 S-8 S-8 0001193125-22-025696 333-262477 22583653 33 88721
2022-01-18 4 FORM 4 SUBMISSION 0000899243-22-002217 9819
2022-01-12 8-K 8-K 7.01,9.01 0001193125-22-007375 001-40335 22525699 34 18287971 1 1
2021-12-07 4 FORM 4 0001567619-21-021722 9423
2021-12-07 4 FORM 4 0001567619-21-021721 9432
2021-12-07 4 FORM 4 0001567619-21-021720 5238
2021-11-15 8-K 8-K 7.01,9.01 0001193125-21-329816 001-40335 211410239 34 8587777 1 1
2021-11-03 10-Q 10-Q 0001564590-21-053957 001-40335 211375465 34 7511130 1 1
2021-11-03 8-K 8-K 2.02,9.01 0001564590-21-053938 001-40335 211375315 34 552887 1 1
2021-09-21 4 FORM 4 SUBMISSION 0000899243-21-036769 5311
2021-09-21 4 FORM 4 SUBMISSION 0000899243-21-036767 5419
2021-09-17 8-K 8-K 8.01,9.01 0001193125-21-276144 001-40335 211260567 34 167920 1 1
2021-08-25 4 FORM 4 0001567619-21-016342 7996
2021-08-25 4 FORM 4 0001567619-21-016341 7986
2021-08-19 4 FORM 4 0001567619-21-016160 11079
2021-08-19 4 FORM 4 0001567619-21-016159 11069
2021-08-11 10-Q 10-Q 0001564590-21-043461 001-40335 211163776 34 7713960 1 1
2021-08-11 8-K 8-K 2.02,9.01 0001564590-21-043443 001-40335 211163610 34 396143 1 1
2021-08-10 SC 13G JANUS HENDERSON OWNS 11% OF BIOMEA 0001274173-21-000102 005-92506 211160863 34 7664
2021-08-05 4 FORM 4 0001567619-21-014561 5238
2021-08-05 3 FORM 3 0001567619-21-014560 10391
2021-07-19 8-K 8-K 7.01,9.01 0001193125-21-218136 001-40335 211096983 34 8242506 1 1
2021-07-12 8-K/A 8-K/A 5.02 0001193125-21-213137 001-40335 211086010 34 153199 1 1
2021-07-09 8-K 8-K 5.02 0001193125-21-211906 001-40335 211083242 34 146839 1 1
2021-06-29 8-K 8-K 5.02 0001193125-21-202589 001-40335 211055531 34 148180 1 1
2021-06-21 4 FORM 4 0001567619-21-012451 5372
2021-06-21 3 FORM 3 0001567619-21-012449 10525
2021-06-17 8-K 8-K 5.02 0001193125-21-192433 001-40335 211023262 34 151052 1 1
2021-05-27 10-Q 10-Q 0001564590-21-030450 001-40335 21973040 34 6694605 1 1
2021-05-27 8-K 8-K 2.02,9.01 0001564590-21-030448 001-40335 21972998 34 314533 1 1
2021-04-30 SC 13G SC 13G 0001193125-21-145339 005-92506 21879007 34 95706
2021-04-30 SC 13D sched13d.htm 0000929638-21-000634 005-92506 21878506 34 99588
2021-04-26 3 FORM 3 SUBMISSION 0000899243-21-016975 3876
2021-04-22 4 FORM 4 0001567619-21-008471 17394
2021-04-20 S-8 S-8 0001193125-21-122954 333-255377 21838500 33 109475
2021-04-20 8-K 8-K 5.03,8.01,9.01 0001193125-21-122857 001-40335 21838112 34 436177 1 1
2021-04-19 4 FORM 4 0001567619-21-008333 13717
2021-04-19 4 FORM 4 SUBMISSION 0000899243-21-016301 5369
2021-04-19 4 FORM 4 SUBMISSION 0000899243-21-016299 5419
2021-04-19 4 FORM 4 SUBMISSION 0000899243-21-016298 5419
2021-04-19 424B4 424B4 0001193125-21-119607 333-254793 21832540 33 4450694
2021-04-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-04-15 16:00:00 9999999995-21-001452 333-254793 21830014 33 1659
2021-04-15 S-1MEF S-1MEF 0001193125-21-118200 333-255271 21829949 33 68122
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-016041 13289
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-016039 13258
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-016038 8088
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-016037 11006
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-016033 9336
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-016031 8015
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-016030 9233
2021-04-15 3 FORM 3 0001567619-21-008170 11231
2021-04-15 CERT 8A CERTIFICATION 0001354457-21-000477 001-40335 21828119 34 74418
2021-04-15 S-1/A S-1/A 0001193125-21-117175 333-254793 21827360 33 4565813
2021-04-15 CORRESP filename1.htm 0001193125-21-117167 31891
2021-04-15 UPLOAD filename1.pdf 0000000000-21-004552 42938
2021-04-14 8-A12B 8-A12B 0001193125-21-116042 001-40335 21825479 34 14032
2021-04-13 CORRESP filename1.htm 0001193125-21-114518 9301
2021-04-13 CORRESP filename1.htm 0001193125-21-114514 7077
2021-04-12 CORRESP filename1.htm 0001193125-21-112501 32122
2021-04-12 S-1/A S-1/A 0001193125-21-112498 333-254793 21819473 33 7163187
2021-04-02 UPLOAD filename1.pdf 0000000000-21-003974 44244
2021-03-26 CORRESP filename1.htm 0001193125-21-096751 41073
2021-03-26 S-1 FORM S-1 0001193125-21-096737 333-254793 21778422 33 5271833
2021-03-12 UPLOAD filename1.pdf 0000000000-21-003031 52860
2021-02-12 DRS filename1.htm 0000950123-21-002023 377-04224 21629269 33 4467048
2021-01-15 D xslFormDX01/primary_doc.xml 06b 0001567619-21-001101 021-386559 21532402 33 6155

Latest XBRL company facts

One latest value per concept from companyfacts (224 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 72.68M 2026-10-29 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
dei EntityPublicFloat Entity Public Float USD 93.61M 2025-06-30 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 36,000 2021-03-31 2021 Q1 10-Q 2021-05-27 0001564590-21-030450
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -1,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 3.12M 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043461
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 478,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 631,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1,000 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 483.55M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.62M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 5,000 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-05 0001193125-26-335085
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4.30M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 50.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 2.21M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap Assets Assets USD 28.10M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AssetsCurrent Assets, Current USD 27.66M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010312
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1,000 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 34.25M 2025-03-31 2025 Q1 10-Q 2025-05-05 0000950170-25-063543
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 34.25M 2025-03-31 2025 Q1 10-Q 2025-05-05 0000950170-25-063543
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 26.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 26.77M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -29.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 37.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 14.47M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 72.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 72.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -26.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 55.73M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022607
us-gaap DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 0 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap DebtSecuritiesRealizedGainLoss Debt Securities, Realized Gain (Loss) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.04M 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007624
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 31,000 2021-03-31 2021 Q1 10-Q 2021-05-27 0001564590-21-030450
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 1.97M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 133.24M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.04M 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 66.43M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 109,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 15.05M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 5.42M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 714,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 133.24M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.90M 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 139,000 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 55,000 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap Depreciation Depreciation USD 76,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.15 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-01 0000950170-22-013678
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.236 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent pure 0.026 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.025 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.029 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.17M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 11.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 100,000 2025-08-11 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -10.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-01 0000950170-22-013678
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-01 0000950170-22-013678
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-01 0000950170-22-013678
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-01 0000950170-22-013678
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 510,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 14.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 1.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 756,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 11,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -167,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 498,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.09M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-27 0001564590-21-030450
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -619,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 398,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap InterestAndOtherIncome Interest and Other Income USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap InterestReceivable Interest Receivable USD 22,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264679
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 115,000 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap Investments Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.65M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.31M 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.53M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.52M 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.47M 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.44M 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.53M 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 3.15M 2024-03-31 2024 Q1 10-Q 2024-05-02 0000950170-24-052082
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 65,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap Liabilities Liabilities USD 20.51M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 28.10M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap LiabilitiesCurrent Liabilities, Current USD 12.77M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap LoansPayableCurrent Loans Payable, Current USD 36,000 2020-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007624
us-gaap LongTermInvestments Long-term Investments USD 1.88M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010312
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 171,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 550,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -30.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -26.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 7,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OperatingExpenses Operating Expenses USD 38.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -38.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 800,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.59M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 506,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.67M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.078 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap OtherAssetsCurrent Other Assets, Current USD 29,000 2020-12-31 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 398,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 1,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 144,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 595,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264679
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 753,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022607
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 38.49M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 362,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 890,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 3.15M 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010312
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.53M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap PrepaidInsurance Prepaid Insurance USD 438,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264679
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 4.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 161.80M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-10-29 0000950170-24-118366
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 5.03M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 55.74M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010312
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 171,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 40.40M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -36,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 1.15M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 550,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-05 0000950170-25-063543
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -26.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 668,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 37,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 36,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022607
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 26.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap RestrictedCash Restricted Cash USD 369,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 26.80M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 369,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -475.97M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap Revenues Revenues USD 1.24B 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022607
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 5.97M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 30 2023-04-03 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap SecurityDeposit Security Deposit USD 0 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264679
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-27 0001564590-21-030450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010312
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.047 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 32.37M 2021-03-31 2021 Q1 10-Q 2021-05-27 0001564590-21-030450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 24.35M 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043461
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.72M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.87 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 441,644 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1,730 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 12.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.11 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap ShortTermInvestments Short-term Investments USD 1.15M 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 28,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 7.59M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 8.84 2021-04-12 2022 FY 10-K 2023-03-28 0000950170-23-010312
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 7.06M 2021-04-19 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 5.75M 2023-04-03 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 8,100 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 55.73M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038026
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 159,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.65M 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-335085
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 12,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053957
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.46M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 60,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 603,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 84,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047775
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 19.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121825
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 72.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 29.16M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-01 0000950170-22-013678
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 72.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455592

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →